Skip to main content
NCBI home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1981 Nov;46(2):412–419.

A study of C3b deposition on yeast surfaces by sera of known opsonic potential.

M W Turner, J F Mowbray, D R Roberton
PMCID: PMC1536409  PMID: 7039889

Abstract

C3c fragments released by the actin of trypsin from C3b molecules bound to zymosan may be readily quantitated by conventional gel techniques to give a measurement of the efficiency of C3b opsonization. Using this approach, the rate of deposition of C3b molecules was found to be very rapid in sera known to opsonize yeast normally. In contrast, sera defective in yeast opsonization deposited C3b much more slowly. The C3b elution technique was found to correlate well with both a direct phagocytosis assay using baker's yeast (r = 0.87, P less than 0.001) and a recently described neutrophil iodide uptake assay (r = 0.88, P less than 0.001).

Full text

PDF
412

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Candy D. C., Larcher V. F., Tripp J. H., Harries J. T., Harvey B. A., Soothill J. F. Yeast opsonisation in children with chronic diarrhoeal states. Arch Dis Child. 1980 Mar;55(3):189–193. doi: 10.1136/adc.55.3.189. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Carlo J. R., Ruddy S., Studer E. J., Conrad D. H. Complement receptor binding of C3b-coated cells treated with C3b inactivator, beta 1H globulin and trypsin. J Immunol. 1979 Aug;123(2):523–528. [PubMed] [Google Scholar]
  3. Ehlenberger A. G., Nussenzweig V. The role of membrane receptors for C3b and C3d in phagocytosis. J Exp Med. 1977 Feb 1;145(2):357–371. doi: 10.1084/jem.145.2.357. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. FAHEY J. L., MCKELVEY E. M. QUANTITATIVE DETERMINATION OF SERUM IMMUNOGLOBULINS IN ANTIBODY-AGAR PLATES. J Immunol. 1965 Jan;94:84–90. [PubMed] [Google Scholar]
  5. Gaither T. A., Hammer C. H., Frank M. M. Studies of the molecular mechanisms of C3b inactivation and a simplified assay of beta 1H and the C3b inactivator (C3bINA). J Immunol. 1979 Sep;123(3):1195–1204. [PubMed] [Google Scholar]
  6. Goldstein I. M., Kaplan H. B., Radin A., Frosch M. Independent effects of IgG and complement upon human polymorphonuclear leukocyte function. J Immunol. 1976 Oct;117(4):1282–1287. [PubMed] [Google Scholar]
  7. Klebanoff S. J., Clark R. A. Iodination by human polymorphonuclear leukocytes: a re-evaluation. J Lab Clin Med. 1977 Mar;89(3):675–686. [PubMed] [Google Scholar]
  8. Levinsky R. J., Harvey B. A., Paleja S. A rapid objective method for measuring the yeast opsonisation activity of serum. J Immunol Methods. 1978;24(3-4):251–256. doi: 10.1016/0022-1759(78)90129-1. [DOI] [PubMed] [Google Scholar]
  9. Roberton D. M., Dhanjal N. K., Levinsky R. J., Mowbray J. F., Turner M. W. Polymorphonuclear neutrophil iodination response as an estimate of defective yeast opsonization. Clin Exp Immunol. 1981 Jan;43(1):208–214. [PMC free article] [PubMed] [Google Scholar]
  10. Roos D., Bot A. A., van Schaik M. L., de Boer M., Daha M. R. Interaction between human neutrophils and zymosan particles: the role of opsonins and divalent cations. J Immunol. 1981 Feb;126(2):433–440. [PubMed] [Google Scholar]
  11. Schenkein H. A., Ruddy S. The role of immunoglobulins in alternative complement pathway activation by zymosan. I. Human IgG with specificity for Zymosan enhances alternative pathway activation by zymosan. J Immunol. 1981 Jan;126(1):7–10. [PubMed] [Google Scholar]
  12. Schenkein H. A., Ruddy S. The role of immunoglobulins in alternative pathway activation by zymosan. II. The effect of IgG on the kinetics of the alternative pathway. J Immunol. 1981 Jan;126(1):11–15. [PubMed] [Google Scholar]
  13. Soothill J. F., Harvey B. A. A defect of the alternative pathway of complement. Clin Exp Immunol. 1977 Jan;27(1):30–33. [PMC free article] [PubMed] [Google Scholar]
  14. Soothill J. F., Harvey B. A. Defective opsonization. A common immunity deficiency. Arch Dis Child. 1976 Feb;51(2):91–99. doi: 10.1136/adc.51.2.91. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Turner M. W., Mowbray J. F., Harvey B. A., Brostoff J., Wells R. S., Soothill J. F. Defective yeast opsonization and C2 deficiency in atopic patients. Clin Exp Immunol. 1978 Nov;34(2):253–259. [PMC free article] [PubMed] [Google Scholar]
  16. Yamamura M., Valdimarsson H. A new semiquantitative radiometric opsonin assay. Selective measurement of opsonizing capacity of the alternative pathway. Immunology. 1978 Apr;34(4):689–694. [PMC free article] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES